CYCC

Cyclacel Pharmaceuticals, Inc. Competitors

$2.96
*  
0.05
1.66%
Get CYCC Alerts
*Delayed - data as of Nov. 28, 2014  -  Find a broker to begin trading CYCC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Cyclacel Pharmaceuticals, Inc.
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Cyclacel Pharmaceuticals, Inc.
CYCCP: NASDAQ-CM
$ 7.05 -0.30 ▼ 844 $ 7.05
$ 7
$ 9.70
$ 7
NE 2,361,750
Cyclacel Pharmaceuticals, Inc.
CYCC: NASDAQ-GM
$ 2.96 -0.05 ▼ 18,038 $ 3.01
$ 2.93
$ 5.25
$ 2.68
NE 67,120,960
Cymabay Therapeutics Inc.
CBAY: NASDAQ-CM
$ 7.23 0.13 ▲ 14,200 $ 7.24
$ 6.96
$ 13.7757
$ 4.47
NE 106,187,010
Cytokinetics, Incorporated
CYTK: NASDAQ-CM
$ 4.67 0.08 ▲ 469,110 $ 4.98
$ 4.58
$ 13.26
$ 3.05
NE 170,964,030
DARA Biosciences, Inc.
DARA: NASDAQ-CM
$ .7818 0.00 ▲ 61,555 $ .8099
$ .77
$ 4.40
$ .74
NE 15,316,244
Depomed, Inc.
DEPO: NASDAQ-GS
$ 15.49 -0.25 ▼ 247,947 $ 15.91
$ 15.47
$ 16
$ 8.075
11.56 905,808,730
Dermira, Inc.
DERM: NASDAQ-GS
$ 17.25 unch 21,969 $ 17.25
$ 17.015
$ 18.50
$ 12.675
NE 424,350,000
Dicerna Pharmaceuticals, Inc.
DRNA: NASDAQ-GS
$ 11.82 -0.11 ▼ 54,570 $ 12
$ 11.66
$ 46
$ 8
NE 210,029,580
Dipexium Pharmaceuticals, Inc.
DPRX: NASDAQ-CM
$ 10.44 0.20 ▲ 3,289 $ 10.44
$ 10.09
$ 15.86
$ 8
NE 89,136,720
Dr. Reddy's Laboratories Ltd
RDY: NYSE
$ 58.39 0.15 ▲ 138,100 $ 58.85
$ 57.99
$ 58.57
$ 38.23
27.29 1,695,295,260
Durect Corporation
DRRX: NASDAQ-GM
$ .92 unch 58,682 $ .95
$ .92
$ 2.69
$ .68
NE 102,669,240
Dynavax Technologies Corporation
DVAX: NASDAQ-CM
$ 14.86 -0.24 ▼ 163,762 $ 15.44
$ 14.8201
$ 21.40
$ 12.50
NE 390,639,680
Eagle Pharmaceuticals, Inc.
EGRX: NASDAQ-GM
$ 12.61 -0.09 ▼ 6,910 $ 12.76
$ 12.4349
$ 16.44
$ 9.16
NE 176,792,200
Egalet Corporation
EGLT: NASDAQ-GM
$ 6.02 -0.32 ▼ 3,075 $ 6.48
$ 6.02
$ 19.85
$ 3.8101
NE 104,049,680
Eleven Biotherapeutics, Inc.
EBIO: NASDAQ-GM
$ 11.38 -0.08 ▼ 3,535 $ 11.54
$ 11.2901
$ 19.3326
$ 9.502
NE 185,186,740
Eli Lilly and Company
LLY: NYSE
$ 68.12 0.80 ▲ 2,237,833 $ 68.55
$ 67.60
$ 68.67
$ 48.88
27.25 75,846,851,600
Emergent Biosolutions, Inc.
EBS: NYSE
$ 24.86 -0.10 ▼ 249,193 $ 25.44
$ 24.67
$ 28.48
$ 19.31
51.79 933,542,720
Enanta Pharmaceuticals, Inc.
ENTA: NASDAQ-GS
$ 46.94 -1.05 ▼ 256,474 $ 49.09
$ 46.509
$ 48.49
$ 25.38
26.67 872,286,020
Endo International plc
ENDP: NASDAQ-GS
$ 73.17 0.76 ▲ 961,269 $ 73.72
$ 72.13
$ 82.16
$ 53.62
NE 11,229,399,900
Endocyte, Inc.
ECYT: NASDAQ-GS
$ 6.49 -0.08 ▼ 446,133 $ 6.81
$ 6.48
$ 33.70
$ 5.31
30.9 269,665,990
EPIRUS Biopharmaceuticals, Inc.
EPRS: NASDAQ-CM
$ 5 -0.32 ▼ 7,232 $ 5.16
$ 4.99
$ 22.50
$ 3.776
NE 64,635,000
Epizyme, Inc.
EPZM: NASDAQ-GS
$ 22.86 0.31 ▲ 122,339 $ 23.26
$ 22.04
$ 41.23
$ 18.75
NE 767,730,240
ERBA Diagnostics, Inc.
ERB: AMEX
$ 2.74 -0.23 ▼ 47,457 $ 2.97
$ 2.6381
$ 4.13
$ 1.39
137 120,581,920
Esperion Therapeutics, Inc.
ESPR: NASDAQ-GM
$ 31.63 -0.20 ▼ 61,574 $ 32.58
$ 31.36
$ 34.42
$ 10.90
NE 622,952,850
Evoke Pharma, Inc.
EVOK: NASDAQ-CM
$ 6.30 0.14 ▲ 1,826 $ 6.45
$ 6.2601
$ 13.40
$ 4.72
NE 38,430,000